A single arm, multicenter, prospective, clinical study on a novel minimally invasive posterier sacroiliac fusion device
Protocol #: 20-2971
Location: Medical Center of the Rockies
|
STUDY OF ANTIMALARIALS IN INCOMPLETE LUPUS ERYTHEMATOSUS (SMILE)
Protocol #: 20-0141
Locations: Barbara Davis Center; University of Colorado Hospital
|
STOP BLOQ: (Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly)
While in this study you will be asked You will be asked to participate (if eligible) in three STEPS:
STEP 1 – a screening step to evaluate the level of antibodies to Ro52 and Ro60 (proteins in your blood);
STEP 2 – This step occurs if you are found to have high amounts of anti-Ro60 or...more >
Protocol #: 20-1310
Location: Childrens Hospital Colorado
|
Slow Heart Registry: A prospective observational cohort study of fetal immune-mediated high degree heart block
Protocol #: 20-0820
Location: Childrens Hospital Colorado
|
Classification of Axial Spondyloarthritis Inception Cohort (CLASSIC) study
The ASAS group has developed classification criteria for axial spondyloarthritis (axSpA) that allow the inclusion of patients with an early form of disease that is not yet clearly visible on plain radiography. These criteria include both an "imaging arm," that incorporates either radiograp...more >
Protocol #: 19-1526
Locations: Barbara Davis Center; Rocky Mountain Regional VA Medical Center; University of Colorado Hospital
|
The Effect of Adjuvant Adipose-Derived Modified Cells for Arthroscopically-Determined Knee Osteoarthritis: A Randomized Controlled Trial
Protocol #: 19-2893
Location: Steadman Hawkins Clinic - Denver (Iverness)
|
Randomized Controlled Trial of the Cartilage Forming Potential of Microdrilling versus Lipoaspirate Concentrate for Isolated Articular Cartilage Defects
Protocol #: 19-2838
Location: Steadman Hawkins Clinic - Denver (Iverness)
|
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Filgotinib in Subjects with Active Psoriatic Arthritis Who Have an Inadequate Response or are Intolerant to Biologic DMARD Therapy
Protocol #: 19-2534
Locations: Barbara Davis Center; University of Colorado Hospital
|
A Phase 3, Randomized, Double-blind, Placebo and Adalimumab-controlled Study to Evaluate the Efficacy and Safety of Filgotinib in Subjects with Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy
Protocol #: 19-2533
Locations: Barbara Davis Center; University of Colorado Hospital
|
Validation of the UCLA Scleroderma Clinical Trial Gastrointestinal Tract Instrument Version 2.0 for Juvenile Systemic Sclerosis
Protocol #: 19-1613
Location: Childrens Hospital Colorado
|
Gait Analysis of Femoroacetabular Impingement Patients
Protocol #: 16-1934
Location: Childrens Hospital Colorado
|
Impact of Novel Therapeutic Music Delivery Device on Drug Use and Recovery in Surgical Patients
Protocol #: 19-6100
Locations: Medical Center of the Rockies; Poudre Valley Hospital
|
Allen CU-UCSD Transition to RA Project: Blood and Flu
Protocol #: 19-1150
Locations: Barbara Davis Center; University of Colorado Hospital
|
Inception Cohort for Juvenile Systemic Sclerosis: A Follow-Up Study Over 3 Years for Children and Young People with Systemic Sclerosis
Protocol #: 19-0814
Location: Childrens Hospital Colorado
|
Total Joint Arthroplasty in a Pediatric Population
Involves two surveys for approximately 10 mintues...more >
Protocol #: 19-0306
Location: Childrens Hospital Colorado
|
A Phase 1b Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of TAK-079 in Combination With Standard Background Therapy in Patients With Moderate to Severe Systemic Lupus Erythematosus
Protocol #: 19-0027
Location: Barbara Davis Center
|
A Phase 2b, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy, safety, and tolerability of cenerimod in subjects with moderate to severe systemic lupus erythematosus (SLE)
Protocol #: 18-2346
Location: University of Colorado Hospital
|
Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis (StopRA)
Protocol #: 15-1868
Locations: Barbara Davis Center; UCD Barbara Davis Center; University of Colorado Hospital
|
Determining the Optimal Treatment Strategy for Patients who have Chronic Migraine with Medication Overuse
Protocol #: 16-2179
Location: University of Colorado Hospital
|
American Registry for Migraine Research
Protocol #: 17-2165
Locations: Lone Tree Medical Center; UCHealth Internal Medical Clinic - Lowry; University of Colorado Hospital
|
Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease (RAPID)
This study is inviting people who have RA into a study to have an HRCT scan and PFT testing done for the study to learn more about lung disease in RA...more >
Protocol #: 16-1097
Location: University of Colorado Hospital
|
Calibrating free-living physical activity characteristics across functionally-limited populations using machine-learned accelerometer approaches
Regular physical activity is known to have positive effects on many health outcomes. In research, physical activity is often measured using activity monitors worn on the hip, wrist or ankle. These instruments determine how much physical activity a person does based on the amount of movemen...more >
Protocol #: 16-2706
Locations: CTRC-adult; University of Colorado Hospital
|
The modified Atkins diet in patients with drug resistant epilepsy and the responsive neurostimulator 09Aug2017
Protocol #: 17-0888
Location: University of Colorado Hospital
|
Program for Individuals with an Elevated Risk of Spondyloarthritis (PIERS)
The Program for Individuals with an Elevated Risk of Spondyloarthritis (PIERS) is a registry proposed by the affiliate members of the University of Colorado Program to Advance Spondyloarthritis Treatment (U.C.PAST). The purpose of PIERS is to identify individuals at risk for spondyloarthri...more >
Protocol #: 17-0977
Location: University of Colorado Hospital
|
Scleroderma Lung Study III (SLS III): Combining the anti-fibrotic effects of pirfenidone (PFD) with mycophenolate (MMF) for treating scleroderma-related interstitial lung disease
Protocol #: 17-1226
Location: University of Colorado Hospital
|
The Colonic Microbiome and Mucosal Immunity in Inflammatory Bowel Disease and Ankylosing Spondylitis
This study uses colonic biopsies to compare immune cell function and gut microbiome between those with IBD, AS, AS/IBD overlap, and healthy controls....more >
Protocol #: 14-1507
Locations: Colorado Research Center; Denver Health and Hospital Authority; University of Colorado Hospital
|
Analysis of Discarded Spinal Tissues from Individuals with Spinal Conditions
Protocol #: 17-0687
Location: University of Colorado Hospital
|
A double-blind, placebo-controlled crossover study comparing the analgesic efficacy of cannabis versus oxycodone
Protocol #: 14-1909
Locations: CTRC-adult; University of Colorado Hospital
|